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Abstract
As one of the primary points of entry of xenobiotic substances and infectious
agents into the body, the lungs are subject to a range of dysfunctions and diseases
that together account for a significant number of patient deaths. In view of this,
there is an outstanding need for in vitro systems in which to assess the impact of
both infectious agents and xenobiotic substances of the lungs. To address this
issue, we have developed a protocol to generate airway epithelial basal-like cells
from induced pluripotent stem cells, which simplifies the manufacture of cellular
models of the human upper airways. Basal-like cells generated in this study were
cultured on transwell inserts to allow formation of a confluent monolayer and then
exposed to an air-liquid interface to induce differentiation into a pseudostratified
epithelial construct with a marked similarity to the upper airway epithelium in vivo.
These constructs contain the component cell types required of an epithelial model
system, produce mucus and functional cilia, and can support SARS-CoV-2 infec-
tion/replication and the secretion of cytokines in a manner similar to that of
in vivo airways. This method offers a readily accessible and highly scalable protocol
for the manufacture of upper airway models that could find applications in devel-
opment of therapies for respiratory viral infections and the assessment of drug
toxicity on the human lungs.
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induced pluripotent stem cells is significant since it paves the way for broader studies of viral
airway infection using a system that can be manufactured reproducibly.
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1 | INTRODUCTION
The outbreak of the novel coronavirus disease, COVID-19, caused by
coronavirus SARS-CoV-2 has been designated as a pandemic by the
World Health Organization and is currently a significant threat to
human health. At the time of submission (February 2021), there were
110 958 312 million confirmed cases, of whom 2 454 901 had died.1
The pandemic has resulted in major challenges to global healthcare
systems and has severe consequences for the global economy if the
spread of the virus is not effectively controlled.
The causative agent of COVID-19, SARS-CoV-2, has been shown
to infect the respiratory system resulting in viral pneumonia, but it
may also affect the gastrointestinal system, heart, kidney, liver, and
central nervous system leading to multiple organ failure.2,3 Previous
studies have shown that SARS-CoV predominantly infects airway and
alveolar epithelial cells, and macrophages4 using the angiotensin-
converting enzyme 2 (ACE2) receptor for entry.5,6 Rapid viral replica-
tion in these cells can lead to epithelial cell apoptosis causing the
release of pro-inflammatory cytokines,7 which can potentially cause
airway damage and diminished patient survival. This is exemplified by
the observation that in SARS-CoV-2-infected individuals, interleukin
(IL)-6, IL-10, and tumor necrosis factor ! (TNF!) surge during illness
and decline during recovery.8 Severely affected patients who require
intensive care treatment can be distinguished by significantly higher
levels of IL-6, IL-10, and TNF! and fewer CD4+ and CD8+ T cells.9
Although it is likely that the ingress of large numbers of cytokine-
secreting inflammatory macrophages into the lung tissue accounts for
a significant proportion of the cytokines detected in such cases, the
initial damage to the airway epithelial cells probably contributes not
only to the overall concentration of cytokines but may also be respon-
sible for recruitment of inflammatory macrophages.
Other mechanisms besides apoptosis can lead to activation of the
inflammasome. The binding of SARS-CoV-2 to the Toll-like receptor
causes the release of pro-IL-1", which is cleaved by caspase-1,
followed by inflammasome activation and production of active mature
IL-1" that mediate lung inflammation, fever, and fibrosis.10 To under-
line this, suppression of pro-inflammatory IL-6 has been shown to
have a therapeutic effect in COVID-19.11 IL-1" can also enhance the
constitutive detachment (or shedding) of an enzymatically active
ectodomain fragment of ACE2 from the airway epithelial cells, an
event associated with acute lung injury.12,13 Interestingly, SARS-
CoV-2 infection is associated with ACE2 downregulation and
ectodomain shedding thought to be induced by the SARS-CoV-2
Spike (S) protein.14,15 How the released form of ACE2 (the so-called
soluble or sACE2) causes lung damage is not completely clear but it
seems to be tightly coupled to TNF! production, so it may be involved
in inflammatory response to SARS-CoV-2 infection.16
Despite this understanding of the mechanisms by which SARS-
CoV-type viruses damage the airway epithelia, there are no effective
treatments for the resulting COVID-19 disease. Current management
of COVID-19 is supportive, and respiratory failure from acute respira-
tory distress syndrome is the leading cause of mortality. In view of
this, there is an urgent and currently unmet need for model systems
that can function as high-throughput preclinical tools for the develop-
ment of novel, effective therapies for COVID-19.
The use of in vitro models mimicking the human airways generated
from primary pulmonary epithelial cells grown at an air-liquid interface
(ALI) has increased in popularity over the recent years. The cells can
form a pseudostratified airway epithelium composed of all in vivo rele-
vant cell types found in the airway epithelium including rare types such
as pulmonary neuroendocrine cells and ionocytes.17 This type of model
has proven to be particularly useful for toxicological assessment of
aerosol particles,18,19 drug discovery,20 and more recently with the
COVID-19 outbreak for viral infection studies.21 Although these models
offer significant advantages, their availability is limited to primary sam-
ples, which can significantly differ depending on the donor's genetic
background and thus affecting the generated airway.
Induced pluripotent stem cells (iPSCs) offer the potential to com-
plement the limitations of primary cells by generating a large supply of
cells with the genetic background of the donor. The pathways
involved in differentiation into proximal and distal airway lineages
have already been established by previous groups, who successfully
differentiated functional ciliated cells, mucus-producing cells, and
alveolar cells.22-26 The current methods of lung differentiation use 3D
self-forming spheroids or 2D cultures of mixed population of cells,
which are more challenging when performing experiments similar to
the primary airway ALI models.27-29 In this study, we isolated a popu-
lation of basal-like cells from differentiating iPSCs and used these to
generate airway epithelial equivalents by ALI culture. We show that
these comprise the cell types found in the human upper airway epi-
thelium including functional ciliated cells, are capable of secreting
mucus, and are readily infected by SARS-CoV-2 as demonstrated by
the replication within the cells of the airway construct, release of
virions into the supernatant growth media, and the presence of SARS-
CoV-2 spike protein in specific cells. Infected constructs also secrete
cytokines at levels corresponding to the behavior of the airway epi-
thelial in vivo following SARS-CoV-2 infection.
2 | MATERIALS AND METHODS
2.1 | Generation of airway epithelial constructs
using airway basal-like cells derived from iPSCs
iPSCs lines SB-AD230 and SB-AD331 were cultured at 37!C with 5%
CO2 on six-well plates coated with Matrigel (BD, 354230) in mTeSR1
(STEMCELL Technologies, 85850) with daily media replacement. At
80% confluency, the cells were passaged with Versene ethylene
diamine tetra-acetic acid (EDTA) 0.02% (Lonza, BE17-711E) for
5 minutes and transferred at a split ratio of 1:3 into fresh Matrigel-
coated plates. The cells were passaged at least twice before initiating
differentiation. All iPSC cultures were performed in a class II biosafety
cabinet laminar airflow tissue culture hood under a
dissection microscope.
Differentiation into airway basal cells involved transit through
definitive endoderm and anterior foregut endoderm stages as follows.
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Briefly, 90% confluent iPSCs were washed with phosphate-buffered
saline (PBS; 2 " 2 mL per well of a six-well plate), then cultured in
Advanced RPMI1640 medium (Thermo Fisher Scientific, Paisley, UK,
12633012) containing 0.02% B27 supplement (Life Technologies Pais-
ley, UK, 17504044) supplemented with 50 U/mL penicillin/strepto-
mycin (Thermo Fisher Scientific, 15140122), 100 ng/mL human
activin A (R&D Systems, Abingdon, UK, 338-AC), 1 #M CHIR99021
(Sigma-Aldrich, Gillingham, UK, SML1046) and 10 #M of Y-27632
(Chemdea Eidgewood, NJ, USA, CD0141). The medium was refreshed
daily for 6 days, and the cells were kept in an incubator at 37!C con-
taining 5% CO2 and 95% humidity. On day 6, the medium was chan-
ged to Advanced RPMI1640 medium containing 0.02% B27
supplement supplemented with 100 ng/mL human recombinant nog-
gin (R&D Systems, 6057-NG) and 10 #M of SB-431542 (R&D Sys-
tems, 1614). The medium was changed daily for 4 days. On day
10, the medium was changed to Advanced RPMI1640 medium
(Thermo Fisher Scientific, 12633012) containing 0.02% B27 sup-
plemented with 100 ng/mL of human recombinant BMP4 (Peprotech
London, UK, 120-05ET), 0.5 #M of all-trans retinoic acid (ATRA)
(Sigma-Aldrich, R2625) and 3 #M of CHIR99021. The medium was
changed every other day for 4 days.
To isolate basal airway-like cells, the day 14 differentiated cells
were washed with PBS and enzymatically detached with trypsin for
5 minutes. The detached cells were centrifuged at 300g and
resuspended in BEGM medium (Lonza, Castleford, UK, CC-4175) sup-
plemented with 10 #M of Y-27632. They were plated at a ratio of one
well into six on mitotically inactivated 3T3 cells. The medium was chan-
ged every other day, until 90% confluency of basal cells is reached. The
basal cells could be passaged at a ratio of 7000 cells/cm2 on irradiated
3T3s for at least eight passages. The cells could also be frozen at 1 mil-
lion per vial in 50% BEGM, 40% fetal bovine serum (FBS), and 10%
Dimethylsulfoxide (DMSO) and stored in liquid nitrogen for later use.
To differentiate these into a pseudostratified airway epithelium,
basal cells at 90% confluency on mitotically inactivated 3T3 feeders
were harvested as a single cell population by trypsinization, then
seeded at a density of 150 000 cells per well onto the apical face of
24-well plate cell culture inserts (ThinCerts, Greiner bio-one, Glouces-
tershire, UK, 662610) with a transparent membrane (PET), with a pore
diameter of 0.4 #m, precoated with Matrigel (1:100) and fibronectin
(1:100) (Sigma Aldrich, F1141). The adherent cells were fed for 3 days
apically and basolaterally with BEGM medium until they formed a
confluent monolayer. Once confluent, the apical medium was
removed, and the cells were fed PneumaCult (STEMCELL
Technologies, Cambridge, UK, 05001) supplemented with heparin,
hydrocortisone and Pen/Strep from the basal chamber. The cells were
cultured over 4 weeks to achieve maturity and fed every other day
from the basal chamber.
Mature ALI cultures prepared in this manner were fixed directly on
the membrane with 4% paraformaldehyde (PFA) for 10 minutes at 3!C
and then washed with PBS (3 " 1.0 mL). The tissues were then
removed together with the membrane, placed into molds, and embed-
ded in optical coherence tomography (OCT) matrix (Cell Path, Newtown,
UK, KMA-0100-00A). The molds were placed at #20!C to solidify. Once
solid, they were sectioned into 5- to 10-#m slices on slides using a cryo-
stat. The sectioned membrane was removed with PBS washes, and the
slides were then stained using the same procedure as the basal cells
using the same antibodies with the addition of antibodies (Tables 1 and
2). Once the staining was finalized, a few drops of Vectashield medium
containing Hoechst were added to the slides then they were covered
with coverslips, sealed with nail polish, and left to dry at 4!C.
2.2 | Characterization of basal epithelial cells by
immunofluorescence and flow cytometry
Basal airway-like cells generated in this manner were characterized by
a combination of flow cytometry (Fortessa flow cytometer and FloJo
analysis) and immunofluorescence (IF) (see Table 1 for a list of anti-
bodies used). At least 10 000 cells were analyzed for each basal-like
cell sample. For IF analysis, basal-like cells were grown on feeder
layers of mitotically inactive 3T3 cells on glass coverslips and cultured
in 24-well plates. The 24-well plates containing coverslips were
washed with PBS (Thermo Fisher Scientific, 10010056) (2 " 1.0 mL)
and fixed with 4% PFA (Sigma-Aldrich, 158127) in PBS for 10 minutes
at 37!C. The cells were washed with PBS (2 " 1.0 mL) then perme-
abilized with 1.0 mL of PBS-0.25% Triton X-100 for 30 minutes. The
permeabilization solution was replaced with blocking solution (2%
Bovine Serum Albumin [BSA] in PBS [w/v]) followed by incubation for
1 hour. Each primary antibody was diluted in 150 #L of the blocking
solution according to the concentrations shown in Table 2. The cells
were then treated with the primary antibodies and incubated at 4!C
(12 hours). Following this, the cells were washed with PBS
(3 " 1.0 mL). Secondary antibodies (Table 2) were prepared in block-
ing solution (1:1000) and added on the samples for 1 hour at room
temperature in the dark. The cells were washed again with PBS
(3 " 1.0 mL). The coverslips were removed from the plate once the
TABLE 1 List of antibodies used for
immunofluorescence and flow cytometric
analysis of basal cells
Antibody name Dilution Species Reference Supplier
Integrin alpha 6 1:100 Mouse Ab30497 Abcam, Cambridge, UK
NGFR 1:100 Mouse 12152170 Thermo Fischer Scientific
Cytokeratin 14 1:100 Mouse Ab210414 Abcam
$Np63 1:400 Rabbit ab167612 Abcam
!-Mouse-AlexaFluor-488 1:1000 Goat A11001 Invitrogen, Paisley, UK
!-Rabbit-AlexaFlour-647 1:1000 Goat A21245 Invitrogen
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staining was finished and placed on a superfrost slide with a few drops
of Vectashield medium containing Hoechst (1:10 000 as a nuclear
counterstain). Coverslips were sealed with nail polish and left to dry in
a dark box before storage at 4!C followed by fluorescence
microscopy.
2.3 | Hematoxylin and eosin staining
ALI cultures were fixed by incubation with 4% PFA/PBS (w/v) for
10 minutes at room temperature. The membrane containing tissues
were surgically removed from the insert and sandwiched between
Shandon sponges (Thermo Fisher Scientific, 85-43) and 3-mm
Whatman paper (GE Healthcare, 9.950371) in tissue embedding cas-
settes. Subsequently, paraffination was performed using the Excelsior
AS Tissue processor (Thermo Fisher Scientific, A82300001), and the
paraffinized tissues were placed into molds. Once the paraffin had
solidified, 3-#m sections were made using a microtome. The slides
were rehydrated using xylene and an ethanol series (100%, 96%, and
70%). Subsequently, the slides were stained using Mayer's hematoxy-
lin (Sigma-Aldrich, MHS32) and alcoholic eosin Y (Sigma-Aldrich,
HT110116) followed by dehydration using an ethanol series (80%,
96%, and 100%). Xylene-washed slides were mechanically covered
using coverslips and dried at room temperature. Histology was
assessed using an AxioVert 25 inverted microscope (Zeiss).
2.4 | Quantification of cilia beat frequency
Prior to imaging, the apical surface of the ALI cultures was washed
using medium from the basal chamber. Subsequently, high-speed
videos were captured using the Nikon Eclipse Ti2 LIPSI high content
imaging microscope equipped with a phase 1 phase contrast ring and a
CFI S Plan Fluor LWD "20 objective. The middle of the Prime BSI
sCMOS camera was used to capture 550 images (512 " 512 pixels)
over 5.5 seconds at a rate of 100 frames per second. During imaging,
the atmosphere was constantly kept at 37!C, 5% CO2, and 95% humid-
ity. At least three fields containing cilia for three inserts were imaged.
For analysis MATLAB was used to calculate cilia beat frequency.
Here, the intensity-time trace of each pixel was filtered for frequencies
between 5 and 25 Hz using a band-pass filter. Subsequently, the power
spectrum density was calculated. The frequency of each pixel is defined
by the highest peak of the power spectrum density. The ciliated cells
were visualized by plotting the frequency of each pixel into a heat map.
The frequency distribution of the ciliated cells was visualized by plotting
the amount of nonzero pixels into a histogram. The average frequency
of all nonzero pixels was compared using a student's t test.
2.5 | Infection of airway epithelial constructs with
SARS-CoV-2
To generate sufficient viral particles for infection experiments, SARS-
CoV-2 isolate REMRQ0001/Human/2020/Liverpool was cultured from a
clinical sample and passaged four times in Vero E6 cells (C1008; African
green monkey kidney cells obtained from Public Health England) cultured
in Dulbecco's minimal essential medium (DMEM) containing 10% FBS
and 0.05 mg/mL gentamycin at 37!C with 5% CO2. The fourth passage
of virus was cultured in Vero E6 cells with DMEM containing 4% FBS
and 0.05 mg/mL gentamycin at 37!C with 5% CO2 and was harvested
48 hours postinoculation. Virus stocks were stored at #80!C.
Virus quantification was performed by standard plaque assays
on Vero E6 cells plated at a density of 6 " 105 cells per well of a
six-well plate. Aliquots of 100 #L of virus stocks over several
dilutions were added to each well of a six-well plate, covered with
overlay medium then incubated at 37!C/5% CO2 for 72 hours,
fixed with 10% formalin and stained with 0.05% crystal violet
solution. The number of noncolored plaques counted in the crystal
violet-stained plate indicated the number of plaque-forming units
(PFU) of the viral dilution.
TABLE 2 List of antibodies used for
immunofluorescence of air-liquid
interface cultures
Antibody name Dilution Species Reference Supplier
$Np63 1:400 Rabbit ab167612 Abcam
Mucin1 1:100 Mouse 11548812 Thermo Fisher Scientific
CC10 1:100 Mouse sc-365992 Santa Cruz, Heidelberg,
Germany
Acetylated Tubulin 1:100 Mouse T6793 Sigma-Aldrich
ZO-1 1:300 Rabbit 61-7300 Invitrogen
Synaptophysin 1:200 Rabbit YE269 Abcam
TMPRSS2 1:900 Rabbit ab92323 Abcam
ACE2 1:200 Goat AF933 R&D Systems
Spike (SARS-CoV-2) 1:100 Rabbit 703959 Invitrogen
Goat !-mouse-AlexaFluor-488 1:1000 Goat A11001 Invitrogen
Goat %-rabbit-AlexaFluor-647 1:1000 Goat A21245 Invitrogen
Donkey %-Goat-Alexa Fluor 1:1000 Donkey A21447 Invitrogen
Donkey !-rabbit-AlexaFluor-546 1:1000 Donkey A10040 Invitrogen
Donkey !-mouse-AlexaFluor-488 1:1000 Donkey A21202 Invitrogen
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Based upon the PFU count of the virus stock, dilutions were
prepared to infect airway epithelial constructs at a multiplicity of
infection (MOI) of 0.01 in DMEM with 4% FBS and gentamycin
(Sigma-Aldrich, 345814-M). Hundred microliters of virus dilution were
added to the apical face of each airway epithelial construct on cell cul-
ture inserts followed by the addition of 250 #L of DMEM (Thermo
Fisher Scientific, 31966047) with 4% FBS and gentamycin. At
each time point, the apical surface of the construct was washed by
adding 1.5 mL of PBS. This is a necessary step since the constructs
survive at an ALI meaning that there is no supernatant liquid
above the apical face. The added PBS “supernatant” from each
infected and control construct was transferred to a 1.5-mL micro-
centrifuge tube, then centrifuged (2500 rpm, 5 minutes) and
stored at #80!C until needed for viral quantification. Samples of
basolateral medium were collected in parallel to the PBS “superna-
tant” washes and to these, Triton X-100 was added to a final con-
centration of 0.5% followed by incubation (room temperature,
30 minutes) to inactivate SARS-CoV-2. The inactivated basolateral
media samples were stored in liquid nitrogen until needed for the
quantification of cytokines. The cellular component of constructs
at each time point was collected for the quantification of viral par-
ticles present within cells and additional constructs for each time
point were fixed with 4% PFA for 30 minutes to provide infected
ALI constructs for analysis by IF. Mock controls, which were
treated the same way except without virus, were included along-
side SARS-CoV-2-infected ALI constructs.
Quantification of viral particles present in the “supernatant” PBS
washes and cellular mass was determined for each time point using
the Vero E6 plaque assay method. The infected constructs were fixed
directly on the membrane with 4% PFA for 10 minutes at 37!C and
then washed three times with PBS for 5 minutes. The tissues were
then removed together with the membrane and placed into molds and
covered with OCT (Cell Path). The molds were placed at #20!C to
solidify. Once solid, they were cryosectioned into 10-#m slices on
slides using a cryostat. The sectioned membrane was removed with
PBS washes and the slides were then stained using the same proce-
dure as the basal-like cells.
ALI cultures analyzed by confocal microscopy were processed as
follows: 24 hours after infection, mock and SARS-CoV-2-infected
whole constructs were fixed in 4% PFA for 45 minutes at room tem-
perature and washed in PBS. The constructs were then permeabilized
in 0.5% Triton X-100 in PBS for 25 minutes at room temperature,
washed in PBS, and blocked in 5% BSA, 20% FBS in PBS for 1 hour at
room temperature. ALI constructs were then incubated with a cocktail
of primary antibodies in blocking solution at 4!C overnight (goat anti-
ACE2 1:200; rabbit anti-Transmembrane protease, serine 2
(TMPRSS2) 1:2000, mouse anti-Spike 1:100; Abcam). After washing,
they were incubated with secondary antibodies in blocking solution
F IGURE 1 Generation of induced pluripotent stem cell (iPSC)-derived airway basal-like cells. A, The schedule of growth factor additions and
media composition for directed differentiation of iPSC via definitive and anterior foregut endoderm stages. After day 14, cells were cultured at
low density on mitotically inactivated mouse 3T3-J2 feeders, B, in the presence of primary airway medium and Rho kinase inhibitor (Y27632) to
generate colonies of basal cells that expressed markers characteristic of airway basal cells derived ex vivo, C, and were expandable for several
passages, D. Scale bars (red) in B, C, and D represent 50 #m. Representative images from six experiments in both iPSC lines are shown
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containing 1 mg/mL of 40,6-diamidino-2-phenylindole for 1 hour at
room temperature (anti-goat AF488, anti-rabbit AF555, anti-mouse
AF647; all Thermo Fisher Scientific 1:1000) and were washed further.
Organoids were embedded in 1% low-melting agarose at 30!C con-
taining Slowfade diamond mounting oil and imaged using a Zeiss
LSM880 confocal laser scanning microscope. At "400, sections were
3D reconstructed from a series of z-stacks (20-40-mm slices) with
automatic optimal thickness and 1 Airyscan unit pinhole. Orthogonal
views were generated using Zeiss Zen 3.3 software.
2.6 | Quantification of cytokine release after
infection with SARS-CoV-2
Quantification of cytokines was performed using the V-PLEX Plus
Viral panel 3 Human Kit purchased from Mesoscale Discovery (MSD,
K15347G-1). The lyophilized cocktail mix calibrators for
Proinflammatory panel 1, Chemokine panels 1 and 4 calibrators for
U-PLEX Biomarker group 1 (calibrators 1, 3, 6, 9) were reconstituted
in provided assay diluents, respectively. U-PLEX plates were coated
with supplied linkers and biotinylated capture antibodies according
to the manufacturer's instructions. Proinflammatory cytokines and
chemokines in basal media collected at 24, 48, and 72 hours after
stimulation were detected with precoated V-PLEX. The assays were
performed according to the manufacturer's protocol at 2 hours incu-
bation of the diluted samples and standards at 4!C. The
electrochemiluminescence signal was detected by MESO QuickPlex
SQ 120 plate reader (MSD) and analyzed with Discovery Workbench
Software (v4.0, MSD). The concentration of each sample was calcu-
lated based on the four-parameter logistic fitting model generated
with the standards (concentration was determined according to the
certificate of analysis provided by MSD). The graphs were plotted
F IGURE 2 Generation of airway epithelial constructs from basal-like cells. A, To induce airway differentiation, induced pluripotent stem cells
(iPSCs)-derived basal cells were plated on a transwell insert, left to grow to confluency then fed from the basal side leaving the apical side in
contact with the air, B. C, Cells with beating cilia were visible as early as 2 weeks of culture and a mucus layer was present on the apical surface
of the construct with multiple hole-like structures. D, Left-hand side panel: Sections of constructs indicate the presence of a pseudostratified
epithelium, in which cells expressing the basal cell marker, delta Np63 are enriched in a layer adjacent to the membrane of the transwell insert.
Differentiation of the basal cells into the other cell types present in the pseudostratified epithelium is indicated by the presence of club cell
protein 10 (CC10) (club cells), and expression of mucin-1 (Muc1) (goblet cells). Expression of synaptophysin (SYN), D, suggests the presence of
pulmonary neuroendocrine cells. The same immunofluorescence analyses were performed in primary lung air-liquid interface (ALI) constructs and
shown in the right-hand panel. Cells are co-stained with Hoechst 33342 (Hoe) to indicate positions of nuclei. Scale bars in C and D
represent 50 #m
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with GraphPad and t test was performed for statistical significance,
*P value >.05, **P value >.001.
3 | RESULTS
3.1 | iPSCs-derived airway basal cells generate
airway epithelial constructs at an ALI
iPSCs were directed to differentiate to definitive endoderm by adding
Activin A and CHIR99021 for 6 days according to the protocol described
by Konishi et al.25 Anterior foregut endoderm was subsequently induced
by dual inhibition of the Transforming growth factor-beta (TGF-beta) sig-
naling by Noggin and SB431542 for 4 days and then inhibition of the
Wnt Pathway by CHIR, ATRA, and BMP4 for additional 4 days was used
to generate a mixed population of lung progenitors (Figure 1A).
These cells were cultured at low density on mitotically inactivated
mouse 3T3-J2 feeders in the presence of primary lung airway
medium BEGM (Lonza, CC-4175 containing the Rho-kinase inhibi-
tor Y27632). Colonies of epithelial-like cells grew within 10 days of
plating (Figure 1B), and these expressed markers previously identi-
fied for airway basal cells markers keratin 14 (KRT14), integrin
alpha 6, NGFR, and $Np6332-34 detectable by IF (Figures 1C and
S1) and/or quantifiable by flow cytometry (Figure S1A). To our
knowledge, this method of enriching and expanding airway basal-
like cells derived from iPSCs has not been reported previously.
These cells responded well to cryopreservation in FBS plus 10%
DMSO and recovered post-thaw to establish colonies on the
3T3-J2 feeders with BEGM supplemented with Rho-kinase inhibi-
tor, Y27632 (Figures 1D and S2). In contrast, iPSC-derived
basal-like cells cultured in BEGM supplemented with Rho-kinase
inhibitor, Y27632 but in the absence of feeder cells, could not be
maintained past passage 4, indicating that culture on 3T3-J2 mitoti-
cally inactivated cells is critical for their continued expansion. Gene
expression studies indicated an upregulation of basal epithelial cell
markers KRT6A, KRT5, and KRT17 upon expansion on 3T3-J2 mitot-
ically inactivated feeder cells (Figure S3, P < .001 for all markers).
To induce airway differentiation, iPSCs-derived basal cells were
allowed to grow to confluency on the 3 T3-J2 feeder layers then
harvested as a single-cell population by trypsinization after removal of
the bulk of the feeder cells by exposure to 0.48 mM sodium EDTA
(Versene, Gibco). The single cells were plated on transwell inserts
(ThinCerts, Greiner bio-one, 662610) (see Figure 2A), left to grow to
confluency (day 3) and then they were fed from the basal side leaving
the apical side in contact with the air (see Figure 2B). To differentiate
the cells into airway epithelia, the commercial PneumaCult media was
used with the addition of 10 #M N-[N-(3,5-Difluorophenacetyl)-L-ala-
nyl]-S-phenylglycine t-butyl ester (DAPT) between differentiation
days 10 and 14. Cells with beating cilia were visible as early as
2 weeks of culture (Figure 2C) and a mucus layer was present on the
apical surface of the construct with multiple hole-like structures
(Figure 2C). IF analysis indicated the presence of a pseudostratified
epithelium (Figure 2D), in which cells expressing the basal cell marker,
p63 were enriched in the basal layer adjacent to the membrane of the
F IGURE 3 Airway epithelial constructs possess tight junctions and functional cilia. A, The apical surface of the pseudostratified epithelium comprises
ciliated epithelial cells capable of forming tight junction indicated by the presence of ZO-1 and cilia indicated by the presence of acetylated tubulin
(AcTub). Scale bars represent 10 #m. B, Cilia are also visible in hematoxylin and eosin-stained sections (indicated by arrows) as early as 2 weeks and the
functionality of these structures is evident from their motility quantified in our measurements of ciliary beat frequency C,D. E, The high levels of trans-
epithelial electrical resistance (TEER) values support the establishment of an epithelial barrier. Data is shown as mean ± SEM, n = 3
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transwell insert. Differentiation of the basal cells into the other cell
types present in the pseudostratified epithelium was indicated by the
presence of club cell protein 10 (club cells, Figure 2D) and the expres-
sion of mucin-1 (goblet cells, Figure 2D). The presence of putative pul-
monary neuroendocrine cells is indicated by the expression of
synaptophysin (Figure 2D). The expression of all the four markers was
similar between iPSC-derived and primary lung cell-derived ALI con-
structs (Figure 2D), although for MUC1 and CC10, the expression in
the primary lung cell-derived ALI constructs was stronger and local-
ized in the very superficial layer.
The apical surface of the pseudostratified epithelium comprises
ciliated epithelial cells capable of forming tight junction indicated
by the presence of ZO-1 and cilia indicated by the presence of
acetylated tubulin (Figure 3A). Cilia are also visible in hematoxy-
linand eosin-stained sections (Figure 3B), and the functionality of
these structures is evident from their motility quantified in
our measurements of ciliary beat frequency (Figure 3C). Pseudo-
stratified airway epithelia constructs generated from iPSCs-
derived basal cells comprised patches of ciliated cells when
compared with higher density of ciliated cells in similar constructs
made from ex vivo-derived primary airway basal cells. Despite
this, the beat frequency of cilia presents on the iPSCs-derived
constructs was in a similar range to those derived from primary
basal cells (12.4 ± 1.6 and 13.6 ± 2.0 Hz, respectively, see
Figure 3D). Moreover, the ability to form tight junctions between
the ciliated epithelial cells probably contributed to the trans
epithelial electrical resistance (TEER) values in the range of
250 to 550 &/cm2 by day 60 (Figure 3E) of culture indicating
establishment of an epithelial barrier.
3.2 | Airway epithelial constructs generated from
iPSCs-derived basal cells are permissive for SARS-
CoV-2 infection and replication
The SARS-CoV-2 genome encodes several structural proteins including
the glycosylated spike protein (S-protein) that mediates cell invasion by
binding to ACE2 on the surface membrane of target cells.35-37 Cell
F IGURE 4 Response of airway epithelial constructs to infection by SARS-CoV-2. A, Schematic presentation of SARS-CoV-2 infection
showing addition of virus on the apical face of iPSC-derived lung ALI constructs. B, Following inoculation of the virus onto the apical face of the
construct at a multiplicity of infection (MOI) of 0.01, the number of viral particles present in the cells of the construct and in the PBS
“supernatant” washes collected from the apical air-liquid interface was assessed with the plaque unit forming assay. Data shown as mean ± SD,
n = 3. Zero hours indicate the plaque forming unit ability of supernatant or cell lysate taken just before SARS-CoV-2 infections. C, Lung airway
epithelial constructs generated in this study express both (angiotensin-converting enzyme 2 [ACE2] and TMPRSS2) proteins required for SARS-
CoV-2 invasion. IF localization of the SARS-CoV-2 spike protein showing that infected cells are clearly visible in greater numbers of the apical
face of the construct. All scale bars (red) represent 50 #m
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invasion also requires S-protein priming, which is facilitated by the host
cell serine protease TMPRSS2. Airway epithelial constructs generated
in this study co-expressed both proteins required for SARS-CoV-2 inva-
sion at the apical face (Figures 4C and S4). We exposed the iPSC-
derived ALI constructs to SARS-CoV-2 at a MOI of 0.01 on the apical
face (Figure 4A). Cell and supernatant samples were harvested at multi-
ple time points after infection and processed for plaque-forming unit
assays as shown in Figure 4B. SARS-CoV-2 productively infected the
iPSC-derived ALI lung constructs, as assessed by live virus titrations on
VeroE6 cells (Figure 4B). SARS-CoV-2 titers remained stable at
72 hours after infection and increased significantly in the supernatant
from 72 to 96 hours (P = .05). Culture supernatants contained similar
levels of infectious virus compared with lysed cellular constructs,
suggesting that the virus was secreted apically. These data underline
the ability of iPSC-derived ALI lung constructs not only to permit entry
of viral particles from the initial inoculum but also to replicate new
virions and release them from the cells. IF analysis of sections and
whole ALI lung constructs showed the presence of Spike protein in
ACE2+TMPRSS2+ cells at the apical face (Figures 4C and S4), further
confirming their infection with SARS-CoV-2.
Airway constructs secrete inflammatory cytokines in response
to SARS-CoV-2 infection (Figure 5). IL-6, IL-12, IL-8, Interferon-
gamma (IFNG), and IL-1" all show increased secretion 48 hours after
infection; however, the greatest (and most statistically significant)
increase is shown by IL-6 equating to a fourfold increase above that
of the uninfected control 48 hours postinfection. In patients with
COVID-19, IL-6 levels are significantly elevated (>2.9-fold greater
than nondiseased individuals)38 and this is associated with adverse
clinical outcomes. Increased cytokine secretion in the infected con-
structs was also observed for IL-12, IL-1", IL-4, and IL-8 at 72 hours
postinfection (Figure 5). Upregulation of cytokines as early as
36 hours postinfection has also been observed in a cellular model of
the lung epithelium based on Calu-3 cells and suggests the cell's
response to SARS-CoV-2 infection, which may or may not be related
to the release of SARS-CoV2 virions into the supernatant.39 In sup-
port of this, it has been shown that SARS-CoV-2 induced IL-1"
secretion depends on the necroptosis, which is an immunogenic cell
death that can trigger inflammatory responses through releasing
inflammatory cytokine and cell damage-associated molecular
patterns.39
The plasma cytokine levels of COVID-19 patients are not exclu-
sively the product of infected epithelial cells as cytokines are also
secreted by activated and/or infected immune cells.39 However, since
the “damage” signals that initiate immune cell recruitment are medi-
ated by cytokines secreted by epithelia, the ability of our model to
reflect this characteristic supports its similarity to in vivo tissue. Secre-
tion of IL-1" is also a characteristic of COVID-19 and since this cyto-
kine is instrumental in the recruitment of monocytes, secretion by our
model is a valuable characteristic.40 Similarly, increased plasma con-
centrations of IL-8 and IL-12 have been observed in COVID-19
patients consistent with their roles in immune cell recruitment. Of
potentially greater interest is the secretion of interferon-', which is
secreted at statistically higher levels in infected constructs vs control
at 48 hours postinfection. Most respiratory viruses induce interferons
in airway epithelial cells41 but IFN-' (interferon-gamma) has been
implicated in pathogenesis of SARS-CoV-2 infection in the human
upper airway.42,43
In conclusion, collectively our data show that airway epithelial
constructs generated from iPSCs-derived basal cells have promise as
models of the response of the airway epithelia to viral infections.
F IGURE 5 Lung airway constructs secrete inflammatory cytokines in response to SARS-CoV-2 infection. Data shown as mean ± SEM, n = 3
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4 | DISCUSSION
In this study, we established an efficient method of isolation of iPSCs-
derived basal-like cells from a mixed population of lung progenitors.
Comparably with primary cells, when grown in BEGM and 3T3-J2
feeders, the iPSC-derived basal cells can self-renew and form colonies.
They express genes associated with a basal cell phenotype (KRT14,
deltaNp63, NGFR, Integrin alpha 6) while maintaining their multipotent
capacity. One other group has reported the isolation of a basal cell-like
population from lung spheroids44 using a 3T3 feeder system with addi-
tion of Rho-kinase inhibitor, but they only isolated a small number of
cells which lost their basal cell characteristics. Our combination of the
monlayer differentiation protocol and transfer the 3T3/Rho kinase
inhibitor system at an early stage of development (differentiation day
14) provides an effective protocol for enriching airway basal-like cells
that can be maintained over multiple passages. During the preparation
of this manuscript, data from another group were published describing
the generation of airway basal-like cells from iPSC45; however, this
method relies upon FACS (Fluorescence Acrivated Cell Sorting) enrich-
ment of NKX2.1+ lung progenitor cells followed by culture as lung
organoids. Airway basal-like cells are obtained by a second FACS
enrichment step from the lung organoids; however, our protocol is
much simpler to apply and generates basal-like cells similar to those
obtained by the published FACS enrichment-based method.
The ability to produce substantial numbers of this cell type,
which are sufficiently robust to recover well from cryopreservation,
makes them applicable for the generation of larger numbers of air-
way constructs in a cost-effective manner. The formation of a pseu-
dostratified epithelium similar to that of the human upper airway by
culture at an ALI recapitulates that observed for primary airway basal
cells. The thickness of the epithelium is between five and eight
layers with ciliated cells being present at the apical face albeit with
fewer ciliated cells compared with epithelia derived from primary
basal cells. Despite this, the ciliated cells are motile and beat within
the same frequency range in both primary and iPSC-derived con-
structs supporting their functional similarities. Moreover, video
recordings support the presence of motile cilia on the apical surface
of iPSC-derived airway constructs (Video S1).
To evaluate the utility of the model for investigation of viral respi-
ratory diseases, we infected iPSC-derived ALI constructs with SARS-
CoV-2. Our findings indicate the presence of surface proteins (ACE2
and TMPRSS2) to which the virus will attach and which are necessary
for cell invasion. Viral replication occurred with release of virions at
the apical surface of the constructs, which was corroborated by
plaque-forming unit assays and IF analyses.
In parallel to quantification of viral particles, secretion of cyto-
kines, chemokines, and molecules which mount a defense against
viral infection were analyzed, thus our model is probably a reason-
able approximation of the human airway epithelium that may be
useful for the investigation of respiratory infectious disease and
the toxicity of diverse xenobiotic substances. The current model
can be expanded to incorporate immune cell components such as
monocytes, neutrophils, macrophages, and dendritic cells since
monitoring the recruitment of such cells and their response to sig-
nals produced by the infected epithelial cells is important for
understanding the consequences of viral infection. Inclusion of
immune cell components will form the next stage of this work.
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